Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals.
about
Meta-analysis of risk factors for Parkinson's disease dementiaThe Genetic Basis of Cognitive Impairment and Dementia in Parkinson's DiseaseBiomarkers for dementia and mild cognitive impairment in Parkinson's disease.Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease.The fluorescent pentameric oligothiophene pFTAA identifies filamentous tau in live neurons cultured from adult P301S tau mice.The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward.The effect of MAPT haplotype on neocortical Lewy body pathology in Parkinson disease.Cognitive decline in Parkinson disease.Genetic risk factors for cognitive decline in Parkinson's disease: a review of the literature.Regional expression of the MAPT gene is associated with loss of hubs in brain networks and cognitive impairment in Parkinson disease and progressive supranuclear palsy.Genetic Architecture of MAPT Gene Region in Parkinson Disease Subtypes.APOE, MAPT, and COMT and Parkinson's Disease Susceptibility and Cognitive Symptom Progression.In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease.Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?Early Gray Matter Volume Loss in MAPT H1H1 de Novo PD Patients: A Possible Association With Cognitive Decline.Can neuroimaging predict dementia in Parkinson's disease?
P2860
Q26743404-672A8636-ACF4-4D27-A0D1-5AA76AE2DAD9Q26744716-0B881BE4-6F6B-4715-B49B-D24D003B9063Q31097119-BF1775F6-33C3-4259-B2FB-3FE7C8036F8DQ33754677-9C413B3E-942A-4279-B783-456C7B57C174Q35662607-670CF2BC-2BB4-426B-94F8-E8BF11761A67Q36332532-D6AB9F6D-1378-468C-B5E1-D15D679F878EQ37082285-55BC8C99-B455-4089-98A1-50AC37EB6280Q38751099-CDB994E1-0BA6-4D01-94AF-40ECA6E8621BQ38755102-C8C29C37-D065-41F8-BA7D-E5B247E96C39Q39327310-49F18E3B-5C72-4C40-B462-AEADC9696A41Q40012093-321247EE-7ED9-4229-9E19-CC25AA7838A0Q40809659-FAE8746E-DB83-4973-B83C-D0194574E852Q47330225-5637A2F5-0A0A-470C-BC4C-BAFB50099FF7Q54982491-7EA318F9-2832-4026-A9B2-DAF5DA5463EBQ55112661-1ADB1FA7-3C8A-4613-9500-67E6880C227BQ58696822-E4C2AD0E-6832-4A51-8534-121DDC69D2C9
P2860
Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Association between MAPT haplo ...... and healthy aging individuals.
@ast
Association between MAPT haplo ...... and healthy aging individuals.
@en
type
label
Association between MAPT haplo ...... and healthy aging individuals.
@ast
Association between MAPT haplo ...... and healthy aging individuals.
@en
prefLabel
Association between MAPT haplo ...... and healthy aging individuals.
@ast
Association between MAPT haplo ...... and healthy aging individuals.
@en
P2093
P2860
P50
P1476
Association between MAPT haplo ...... and healthy aging individuals.
@en
P2093
Adam Hampshire
Adrian M Owen
Sophie E Winder-Rhodes
P2860
P304
P356
10.1016/J.NEUROBIOLAGING.2014.12.006
P577
2014-12-11T00:00:00Z